Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study

BACKGROUND: Drug-induced liver injury (DILI) is a common complication of tuberculosis treatment. We utilised data from the REMoxTB clinical trial to describe the incidence of predisposing factors and the natural history in patients with liver enzyme levels elevated in response to tuberculosis treatm...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Med
Glavni autori: Tweed, Conor Duncan, Wills, Genevieve Helen, Crook, Angela M., Dawson, Rodney, Diacon, Andreas H., Louw, Cheryl E., McHugh, Timothy D., Mendel, Carl, Meredith, Sarah, Mohapi, Lerato, Murphy, Michael E., Murray, Stephen, Murthy, Sara, Nunn, Andrew J., Phillips, Patrick P. J., Singh, Kasha, Spigelman, M., Gillespie, S. H.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875008/
https://ncbi.nlm.nih.gov/pubmed/29592805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-018-1033-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items